January 5, 2009:
Mark Banaszak Holl, professor of chemistry and of macromolecular science and engineering at the University of Michigan, was elected as a fellow of American Association for the Advancement of Science (AAAS).
"Banaszak Holl studies the development of polymer-based drug transport agents and their interactions with lipid bilayers, organelles and cells. He was honored by AAAS for distinguished contributions bridging disciplinary boundaries in studies of chemical and biochemical processes at the nanoscale." The University Record.
Tuesday, December 2, 2008; 2:30 PM, Paul Edward Makidon will do his Final Oral Examination for his thesis
OIL-IN-WATER NANOEMULSIONS AS MUCOSAL VACCINE ADJUVANTS:
CHARACTERIZATION, MECHANISM, FORMULATION, AND DEVELOPMENT OF A
NANOEMULSION-BASED BURKHOLDRERIA CENOCEPACIA VACCINE
Location: 1170A and 1150B BSRB
Chair: James R. Baker, Jr.
August 13, 2008
Nano vaccine for hepatitis B produces strong immunity
April 21 , 2008 - Dr. James R. Baker Jr. has been named the Distinguished University Innovator for 2008. |
Baker, a scientist in the Medical School and a successful entrepreneur, has conducted breakthrough research in nanotechnology materials and launched two startup companies based on the results.
On Monday afternoon, March 31, 2008, we held our endowed Nanotechnology Symposium named in honor of one of our benefactors, Mr. Herbert D. Doan, the former Chairman of the Dow Chemical Company. The program featured speakers who reflect the cross-disciplinary nature of the Institute: Charles Cantor, Ph.D. Chief Scientific Officer, Sequenom, San Diego, CA and James W. Schneider, PhD, Associate Professor of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA. Click for further information.
|
